SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001683168-20-001922
Filing Date
2020-06-10
Accepted
2020-06-10 08:08:36
Documents
1
Group Members
BRISTOL CAPITAL, LLCBRISTOL INVESTMENT FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G bristol_sch13g-060920.htm SC 13G 71233
  Complete submission text file 0001683168-20-001922.txt   73230
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-32837 | Film No.: 20953561
SIC: 2834 Pharmaceutical Preparations

Mailing Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205
Business Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205 (310) 331-8485
BRISTOL INVESTMENT FUND LTD (Filed by) CIK: 0001174866 (see all company filings)

IRS No.: 000000000
Type: SC 13G